0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ç×¾ÏÈ­Çпä¹ýÀ» ¹Þ´Â ¾ÏȯÀÚÀÇ ¸»ÃʽŰ溴Áõ°ú ¿ì¿ï

Chemotherapy-induced Peripheral Neuropathy and Depression in Cancer Patients

Á¾¾ç°£È£¿¬±¸ 2015³â 15±Ç 3È£ p.149 ~ 155
KMID : 1035120150150030149
±è°æ¿¬ ( Kim Kyung-Yeon ) - Çѱ¹¿øÀÚ·ÂÀÇÇпø

À̽ÂÈñ ( Lee Seung-Hee ) - Çѱ¹¿øÀÚ·ÂÀÇÇпø
¿Àº¹ÀÚ ( Oh Pok-Ja ) - »ïÀ°´ëÇб³ °£È£Çаú

Abstract

Purpose: The purpose of this study was to assess chemotherapy induced peripheral neuropathy (CIPN) and to examine the relationship between CIPN and depression.

Methods: A purposive sample of 105 patients treated with chemotherapy were recruited in the cross-sectional survey design. Data were collected using self-report questionnaires. The instruments used were the Chemotherapy Induced Peripheral Neuropathy Assessment Tool (CIPNAT) and Hospital Anxiety Depression Scale (HADS).

Results: The most frequent suffering symptom of CIPN was ¡¯tingling feeling in the hand and foot¡¯. Of the motor symptoms, ¡¯muscle weakness¡¯ was the most frequent symptom and ¡¯muscle or joint aches¡¯ was the strongest suffering symptom of CIPN. The mean score for suffering of CIPN was 4.1. The mean score was 1.04 for depression and the prevalence was 48.5%. CIPN was significantly positively correlated with depression (r=.38, p<.001). The result of simple regression analysis revealed that CIPN was predictive of depression (R2=.136, p<.001).

Conclusion: Based on the findings of this study, nursing intervention programs focusing on CIPN management and alleviating depression are recommended.
KeyWords
¸»ÃʽŰ溯º´, ¾Ï, ¿ì¿ï
Peripheral Neuropathies, Neoplasms, Depression
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed